港股異動 | 恆基地產(00012.HK)跌超4% 2019年度淨利下滑26%
格隆匯3月24日丨恆基地產(00012.HK)今日股價逆勢下跌,現報27.1港元,跌4.41%,暫成交1.89億港元,最新總市值1309億港元。近期走出5連跌行情,創2017年2月以來新低。恆基地產昨日公佈2019年年度業績,公司2019年實現淨利146.4億港元,去年同期為197.65億港元,同比下滑26%。期內股東應占溢利169.94億港元,同比降45.5%。值得一提的是,公司自2012年來首度取消分派紅股,集團只宣佈建議派發末期息每股1.3港元。香港經濟前景仍面對多項不利因素,集團在香港物業之租金及價值受壓。但公司去年香港租金收入升2%,平均出租率97%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.